8:30 am
Registration and Morning Networking
9:00 am Chairperson’s Opening Remarks
OPTIMIZING THE ROLE OF MEDICAL AFFAIRS IN IMPROVING MARKET ACCESS
9:10 am The Role of Medical Managed Care Teams in Educating Payers on the Value of Gene Therapies to Support Optimal Patient Access
Synopsis
- Discover how Medical Managed Care Teams are engaging and educating cross-functional payer teams on gene therapy topics
- Discover how KOL’s are being engaged and educated to support payer interactions
- Assess the key steps to engaging early adopters and building therapeutic advocates within KOL and payer communities
- Understand how KOL and payer insights are being gathered and relayed to Market Access teams to ensure realistic and viable proposals are being delivered
9:40 am Identify the Education Programs for Referral Sites that Support Accurate Information Sharing with HCPs to Improve Patient Enrolment
Synopsis
- Unique challenges associated with referring patients to gene therapy protocols
- Targeted HCP education can enable informed patient referrals to gene therapy protocols
10:10 am
Morning Coffee Break
MAXIMIZING THE VALUE OF MEDICAL AFFAIRS WHEN ENGAGING IN CROSS-FUNCTIONAL COLLABORATIONS
10:40 am Panel Discussion: What Is the Role of Medical Affairs in the Launch of a Gene Therapy
Synopsis
- How can medical affairs prepare the market for an imminent launch beyond reactive responses?
- How should medical affairs promote the distinctive features of a clinical program?
- How do you keep KOL’s engaged and the gene therapy front of mind in a complaint manner?
11:30 am Integrated Evidence Planning For Cross-Functional Evidence Generation in Gene Therapy
Synopsis
- Introduce the development of an Integrated Evidence Plan
- Identify and gain an understanding of common mistakes encountered during the traditional evidence generation approach
- Recognize and appreciate the evolving and increased stakeholder evidence demands
- Discuss best practices for IEP development
12:00 pm
Lunch & Networking
DEFINING THE VALUE OF MEDICAL AFFAIRS WHEN ENGAGING IN CROSS-FUNCTIONAL COLLABORATIONS
1:00 pm Field Medical Value Throughout the Drug Lifecycle
Synopsis
- Discover how Medical Affairs teams are working collaboratively with Clinical Development teams and the approaches being adopted to define clear definition of roles that mitigate a historic ‘territorial’ nature
- Understand the steps taken to create partnerships with Clinical Operations and Development teams and assess examples of positive working dynamics
- Learn how best to demonstrate the access Medical Affairs can provide to Clinical teams
- Identify how platforms are being built to monetize Medical Affairs outputs to successfully demonstrate value
ENHANCING THE VALUE OF MEDICAL AFFAIRS IN A LAUNCH ENVIRONMENT
1:50 pm Uncover How To Demonstrate The Incremental Value of Gene Therapies in a Space Where Other Treatment Options Exist and There Is a Perception of Little Unmet Need
Synopsis
- Identify how gene therapy developers are disrupting therapeutic areas such as Hemophilia, where non gene therapy treatment options exist and are currently valued
- Discuss how adopting a co-creation model with physicians and patient advocacy groups increases ‘buy in’ and strengthens the value story
2:20 pm Chairs Closing Remarks
2:30 pm End of Conference
